Biomarkers-based personalized follow-up in chronic heart failure improves patient’s outcomes and reduces care associate cost

Biomarkers-based personalized follow-up in chronic heart failure improves patient’s outcomes and reduces care associate cost

Abstract Background Heart failure (HF) is a major and growing medical and economic problem, with high prevalence and incidence rates worldwide. Cardiac Biomarker is emerging as a novel tool for improving management of patients with HF with a reduced left ventricular ejection fraction (HFrEF). Method...

Full description

Bibliographic Details
Main Authors: Antonio Leon-Justel, Jose I. Morgado Garcia-Polavieja, Ana Isabel Alvarez-Rios, Francisco Jose Caro Fernandez, Pedro Agustin Pajaro Merino, Elena Galvez Rios, Ignacio Vazquez-Rico, Jose Francisco Diaz Fernandez
Format: Article
Language:English
Published: BMC 2021-05-01
Series:Health and Quality of Life Outcomes
Subjects:
Heart failure
Personalized medicine
Patient value
Patient outcomes
Budget impact
Biomarkers
Online Access:https://doi.org/10.1186/s12955-021-01779-9

Internet

https://doi.org/10.1186/s12955-021-01779-9

Similar Items